Opportunity Information: Apply for PAR 18 800

This funding opportunity, titled "Biomarkers Discovery in Parkinsonism (U01 Clinical Trial Optional)" (PAR-18-800), is an NIH cooperative agreement aimed at supporting hypothesis-driven studies that identify and develop human biomarkers for Parkinson's disease (PD) and related parkinsonian syndromes. It sits within the National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Biomarkers Program (PDBP), meaning projects are expected to align with PDBP priorities and operate in a way that contributes to a broader, coordinated biomarker discovery effort rather than functioning as isolated studies. The "U01" mechanism signals substantial NIH scientific involvement during the project, and "clinical trial optional" indicates applicants may propose studies that include clinical trial elements, but they are not required.

Scientifically, the FOA emphasizes biomarker discovery that can clarify disease biology and improve diagnostic precision across a set of clinically overlapping disorders. It encourages proposals in three main areas. First, it prioritizes genetically causal Parkinson's disease, particularly work that targets specific PD subtypes. This includes studies built around genetic cohorts, biologically defined cohorts of idiopathic PD, and research focused on ethnic subgroups of idiopathic PD, reflecting an interest in stratification and heterogeneity rather than treating PD as a single uniform condition. Second, it supports biomarker approaches that can distinguish synucleinopathies such as PD and multiple system atrophy (MSA) from tauopathies such as progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Third, it encourages tools and markers that improve diagnostic differentiation between idiopathic PD (and its subtypes) and these related neurodegenerative conditions, as well as differentiation from essential tremor, which commonly overlaps symptomatically and can complicate early diagnosis.

A central expectation of this announcement is broad sharing of biospecimens and the data linked to them. Because the FOA is part of the PDBP, the ability to contribute samples, datasets, and associated metadata in a way that enables reuse and validation by the wider research community is treated as a core feature rather than an optional add-on. In practice, that means proposals are expected to incorporate plans and infrastructure for managing biospecimens and data so they can be shared responsibly, consistently, and in a form that supports downstream replication and cross-cohort comparisons.

From an application and oversight standpoint, the FOA requires a detailed project timeline with concrete milestones. These milestones matter in two ways: they are used during peer review to judge feasibility and rigor, and they are also used after an award is made to evaluate progress for continued funding in non-competing years. This places a premium on realistic staging of recruitment, specimen acquisition, assay development or validation steps, analysis, and data release, with clear go/no-go or decision points that NIH can use to track whether the project is delivering what it promised.

Eligibility is broad across U.S.-based organizations. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; certain tribal organizations; public housing authorities/Indian housing authorities; nonprofits (with or without 501(c)(3) status); for-profit entities (other than small businesses); and small businesses, among others. The FOA also explicitly calls out additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and U.S. territories or possessions. At the same time, foreign institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed, keeping the work fully domestic in terms of performance and institutional participation.

Administratively, the opportunity is categorized as discretionary funding using a cooperative agreement (U01) under the health activity area, with CFDA number 93.853 and the sponsoring agency listed as the National Institutes of Health. The original closing date shown for this specific listing is September 6, 2018, and the creation date is May 23, 2018. The listing does not specify an award ceiling or expected number of awards in the provided fields, which typically means applicants would need to consult the full FOA text or NIH guidance for budget expectations and programmatic constraints. Overall, the announcement is designed to accelerate biomarker discovery and disease differentiation in parkinsonism by pushing projects toward well-justified hypotheses, measurable progress milestones, and strong community-oriented sharing of specimens and data through the PDBP framework.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Biomarkers Discovery In Parkinsonism (U01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853.
  • This funding opportunity was created on 2018-05-23.
  • Applicants must submit their applications by 2018-09-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 800

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)

Previous opportunity: Monitoring Estuarine Condition in Coastal Parks

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 800

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 800) also looked into and applied for these:

Funding Opportunity
NIOSH Small Research Grant Program Apply for PAR 18 797

Funding Number: PAR 18 797
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $50,000
K01 Mentored Research Scientist Development Award Apply for PAR 18 799

Funding Number: PAR 18 799
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $100,000
NIOSH Exploratory/Developmental Grant Program (R21) Apply for PAR 18 798

Funding Number: PAR 18 798
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $200,000
Occupational Safety and Health Research (R01) Apply for PAR 18 812

Funding Number: PAR 18 812
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $400,000
Yemen Systems, Health and Resiliency Project (SHARP) Apply for 72027918R00001

Funding Number: 72027918R00001
Agency: Agency for International Development
Category: Health
Funding Amount: Case Dependent
Better Defining Growth Medium to Improve Reproducibility of Cell Culture (SBIR) (R43/R44 - Clinical Trial Not Allowed) Apply for PA 18 815

Funding Number: PA 18 815
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Better Defining Growth Medium to Improve Reproducibility of Cell Culture (STTR) (R41/R42 - Clinical Trial Not Allowed) Apply for PA 18 816

Funding Number: PA 18 816
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Lab to Marketplace: Tools for Brain and Behavioral Research (R43/R44 - Clinical Trial Optional) Apply for PA 18 819

Funding Number: PA 18 819
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) Apply for PAR 18 820

Funding Number: PAR 18 820
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Roybal Centers for Translational Research on Aging (P30 - Clinical Trial Required) Apply for RFA AG 19 006

Funding Number: RFA AG 19 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Roybal Centers for Translational Research on Dementia Care Provider Support (P30 - Clinical Trial Required) Apply for RFA AG 19 007

Funding Number: RFA AG 19 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Collaborative Activities to Promote Cancer Cachexia Research (Admin Supp - Clinical Trial Not Allowed) Apply for PA 18 821

Funding Number: PA 18 821
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed) Apply for PAR 18 822

Funding Number: PAR 18 822
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Exploratory Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R21 - Clinical Trial Not Allowed) Apply for PA 18 824

Funding Number: PA 18 824
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) Apply for RFA AG 19 017

Funding Number: RFA AG 19 017
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Analyses of Adherence Strategies and Data Sets from CALERIE to Explore Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R01 - Clinical Trial Not Allowed) Apply for PA 18 825

Funding Number: PA 18 825
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Exploratory Analyses of Adherence Strategies and Data Sets from CALERIE to Investigate Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R21 - Clinical Trial Not Allowed) Apply for PA 18 826

Funding Number: PA 18 826
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Required) Apply for RFA AG 19 018

Funding Number: RFA AG 19 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 - Clinical Trial Not Allowed) Apply for PA 18 823

Funding Number: PA 18 823
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) Apply for RFA TR 18 021

Funding Number: RFA TR 18 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 800", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: